EHA 2018 Stockholm

Begrüßung & Einführung | Prof. Dr. med. Michael Hallek

Hodgkin Lymphom | Prof. Dr. med. Dr. h.c. Andreas Engert

Multiples Myelom | Prof. Dr. med. Hartmut Goldschmidt

Chronische lymphatische Leukämie (CLL) | PD Dr. med. Barbara Eichhorst

Indolente Lymphome | Prof. Dr. med. Martin Dreyling

Aggressive Lymphome | Prof. Dr. med. Bertram Glaß

CAR-T-Zell-Therapien | Prof. Dr. med. Peter Borchmann